Latest News
In this Issue
Most Popular on DTE Site
- Public Deprived System 3
- Poison in disguise 2
- In celebration of biodiversity 4
- Chaos in the iron age 3
- A treaty too many 1
- Auroville’s alternative galaxy 1
- It’s a demographic disaster
- Health ministry sets timeframe for keeping animals treated with antibiotics out of food chain
- Gujarat pollution board gets a makeover in efficiency 33
- Stage set for GM crops
- Environment ministry wants to restore night traffic through Bandipur tiger reserve 52
- A green facade 44
- Diesel: when bad policy makes for toxic hell 38
- Gujarat pollution board gets a makeover in efficiency 33
- What’s good insulation? 30
- How vulnerable are India's nuclear power plants to disaster 28
- Grand distraction called river interlinking 28
- Eat at your own risk 27
- Green energy takes toll on green cover 26
- Temporary solution, permanent jam 25
On Facebook
The Fortnight
A BITTER PILL
0 Comments
Issue Date: Aug 15, 1996
The world's largest seller of pharmaceuticals, Glaxo Wellcome of UK, lost the latest round of a protracted legal battle in the US. A North Carolina court ruling on July 5 gave the green signal to Novopharm, the Canadian drugs company, to retail a generic version of Zantac when Glaxo's patent on this version of the drug expires in July 1997. The UK group had contended that Novopharm could not have developed the generic version of Zantac without violating a patent taken out on a second version of Zantac. Last year, Glaxo had netted US $3.4 billion from sales of the drug.
O
P
E
N
DTE Must Read
For more info on Auroville:
http://www.auroville.org...
Congratulations, it is an eye opener to other states that are thinking of such schemes.
In Hyderabad, the government...
Thanks. You have raised a very pertinent issue. My family is a great lover of Makhana and we use it in different ways. Slowly...